Synergy is working on a treatment for chronic idiopathic constipation CIC and constipationpredominant irritable bowel syndrome IBSC. 이 임상시험의 결과는 4분기에 나올 예정입니다. If positive, that could put the treatment on the path to approval and Synergy shares on the path to.